Skip to main content
Modular Medical, Inc. logo

Modular Medical, Inc. — Investor Relations & Filings

Ticker · MODD ISIN · US60785L2079 US Manufacturing
Open in API
Filings indexed 571 across all filing types
Latest filing 2017-04-27 Director's Dealing
Country US United States of America
Listing US MODD

About Modular Medical, Inc.

https://www.modularmedical.com/

Modular Medical, Inc. is a development-stage medical device company that designs, develops, and intends to commercialize insulin pump technology for diabetes care. The company's primary product is the MODD1 insulin pump, which is engineered for simplicity, affordability, and ease of use. The device is intended to facilitate a smooth transition for individuals moving from multiple daily injections to pump therapy. Modular Medical aims to make advanced diabetes technology more accessible to a broader community of patients and their healthcare providers by removing the complexities associated with traditional insulin delivery systems.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2017-04-27 English
CURRENT REPORT ON FORM 8-K DATED APRIL 5, 2017
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filing dated April 5, 2017, which is a Current Report pursuant to the Securities Exchange Act of 1934. The content describes the entry into a material definitive agreement, specifically a Common Stock Purchase Agreement involving a share acquisition and changes in officers and directors. It includes details about the transaction and references an attached Stock Purchase Agreement as an exhibit. This type of filing is an update on financing and capital structure changes rather than a full financial report or earnings release. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is 4083 characters, which is consistent with a detailed announcement rather than a brief notice or a full annual/interim report.
2017-04-05 English
SCHEDULE 14F-1
Proxy Solicitation & Information Statement Classification · 95% confidence The document is titled 'Schedule 14F-1 Information Statement pursuant to Section 14(f) of the Securities Exchange Act of 1934 and Rule 14f-1 thereunder.' It is filed with the SEC and relates to a change of control transaction involving the company's board of directors and officers. The document provides detailed information about the transaction, including share purchases, resignations, appointments of new directors and officers, and related agreements. It is an information statement provided to shareholders, not a proxy solicitation, and it is not a financial report or earnings release. The content focuses on governance changes and shareholder information related to a change of control. This matches the description of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings or corporate actions. Therefore, the appropriate classification is PSI.
2017-04-05 English
QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED DECEMBER 31, 2016
Interim / Quarterly Report H1 2017
2017-02-10 English
QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED SEPTEMBER 30, 2016
Interim / Quarterly Report Q1 2017
2016-11-10 English
ANNUAL REPORT ON FORM 10K FOR THE YEAR ENDED JUNE 30, 2016
Annual Report FY 2016
2016-09-26 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.